Any current/future new fundraising through debt or equity?

No immediate plans for new ESOPs or equity fundraising as per Balkishan Jalan (Page 10). Company currently has no long-term debt on the books (Page 6). Existing funds include Rs. 25+ crores from IPO corpus plus healthy cash accruals to support organic growth for the next 3-5 years (Page 6). For organic expansions such as Chennai and Wada plants, funding is expected to come from internal accruals and IPO corpus without raising new debt (Page 6). Inorganic growth is being explored with AVP strategy and merchant bankers appointed, but it is too premature to comment on funding; possible future fun

Any current/future capex/capital investment/strategic investment?

Chennai plant Phase 1 CAPEX is nearly complete; commercial production started July 2025 with dispatches from August. Chennai Phase 2 CAPEX (approx. Rs. 15-20 crores) planned to start by last quarter of FY’26. Wada plant CAPEX ongoing as per DRHP; incremental yearly capex based on order book progress. Total CAPEX for Chennai expected around Rs. 48-50 crores, aiming for peak revenue of Rs. 120 crore by FY’27/FY’28. Current capacity expected to reach revenue of Rs. 425-450 crore depending on product mix. Company is scouting for land in Chennai and Maharashtra for further expansion over next 6 mon

Future growth expectations in sales/revenue/volumes?

The company targets a revenue capacity of approximately Rs. 425 crores from the combined Wada and Chennai plants after full CAPEX deployment, depending on product mix. Chennai plant's peak revenue potential post phase two CAPEX is around Rs. 120 crores by FY'27 end or FY'28. Chennai phase 1 production has started; phase 2 CAPEX (Rs. 15-20 crores) to commence in next 2-3 quarters. Wada plant expansion expected to be completed in 6-9 months; Chennai plant expansion in 1-1.5 years. Mid- to long-term organic growth is targeted at 20% year-on-year with maintained EBITDA margins of 17%-19%.

Future growth expectations in earnings/operating earnings/profits/EPS?

The company targets 20-25% growth for FY’26 with a mid- to long-term average growth of around 20% year-on-year. EBITDA margins are expected to be maintained in the 17%-19% range, with potential temporary dips due to Forex impacts. Chennai plant capacity expansion anticipates revenue reaching approximately Rs. 120 crores by FY’27 end or FY’28. Wada and Chennai plants combined full CAPEX deployment could yield a capacity of about Rs. 425 crores, depending on product mix. The company expects utilization ramp-up and revenue growth aligned with capacity expansions over the next 1-2 years. Net profi

Current/ Expected Orderbook/ Pending Orders?

Current order book stands at approximately Rs. 70 crores, which is to be delivered in the next 3-4 months. This order book includes firm schedules and regular OEM schedules for dispatching. The company regularly receives projections and firm orders 1-2 months in advance. Orders are contributed mainly from renewable (37%), industrial (35%), and mobility sectors (28%). There is strong market demand and pressure to deliver, with no signs of sluggishness or cancellations. Fastener business shows strong growth with sequential revenue increase from Rs. 12 crores to Rs. 20 crores in Q1 FY26. Chennai

Gala Precis. EngQ1 FY26Industrial Manufacturing

Gala Precis. Eng Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,158P/E: 38.7Market Cap: ₹1.5K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 2

The company targets a revenue capacity of approximately Rs. 425 crores from the combined Wada and Chennai plants after full CAPEX deployment, depending on product mix.
Chennai plant's peak revenue potential post phase two CAPEX is around Rs. 120 crores by FY'27 end or FY'28.
Chennai phase 1 production has started; phase 2 CAPEX (Rs. 15-20 crores) to commence in next 2-3 quarters.
Wada plant expansion expected to be completed in 6-9 months; Chennai plant expansion in 1-1.5 years.
Mid- to long-term organic growth is targeted at 20% year-on-year with maintained EBITDA margins of 17%-19%.
Current order book stands at Rs. 70 crores, indicating strong demand and client stickiness.
The company is exploring inorganic growth opportunities in precision engineering and fasteners but is premature to comment on specifics.

Margin guidance

Category 3

The company targets 20-25% growth for FY’26 with a mid- to long-term average growth of around 20% year-on-year.
EBITDA margins are expected to be maintained in the 17%-19% range, with potential temporary dips due to Forex impacts.
Chennai plant capacity expansion anticipates revenue reaching approximately Rs. 120 crores by FY’27 end or FY’28.
Wada and Chennai plants combined full CAPEX deployment could yield a capacity of about Rs. 425 crores, depending on product mix.
The company expects utilization ramp-up and revenue growth aligned with capacity expansions over the next 1-2 years.
Net profit growth was 3.2% YoY in Q1 FY’26, despite some quarter-on-quarter impact due to Forex and operational expenses.
The company aims to maintain robust order books (currently at Rs. 70 crores) supporting sustained revenue growth.

See what Gala Precis. Eng management said on margin guidance — free account, 30 seconds.

Fundraise plans

No immediate plans for new ESOPs or equity fundraising as per Balkishan Jalan (Page 10).
Company currently has no long-term debt on the books (Page 6).
Existing funds include Rs. 25+ crores from IPO corpus plus healthy cash accruals to support organic growth for the next 3-5 years (Page 6).
For organic expansions such as Chennai and Wada plants, funding is expected to come from internal accruals and IPO corpus without raising new debt (Page 6).
Inorganic growth is being explored with AVP strategy and merchant bankers appointed, but it is too premature to comment on funding; possible future funding needs may arise (Page 5).
Overall, internal funds and cash are sufficient currently, and no explicit statements about upcoming debt or equity fundraising were made.

Order book

Yes

Current order book stands at approximately Rs. 70 crores, which is to be delivered in the next 3-4 months.
This order book includes firm schedules and regular OEM schedules for dispatching.
The company regularly receives projections and firm orders 1-2 months in advance.
Orders are contributed mainly from renewable (37%), industrial (35%), and mobility sectors (28%).
There is strong market demand and pressure to deliver, with no signs of sluggishness or cancellations.
Fastener business shows strong growth with sequential revenue increase from Rs. 12 crores to Rs. 20 crores in Q1 FY26.
Chennai plant's Phase 1 CAPEX is complete with production started; Phase 2 CAPEX is expected in late FY26.
Peak revenue expected from Chennai plant after expansion is around Rs. 120 crores by FY27/FY28.
Wada and Chennai combined capacity post-CAPEX could reach Rs. 425 crores, depending on product mix.

See what Gala Precis. Eng management said on order book — free account, 30 seconds.

Capex plans

Yes

Chennai plant Phase 1 CAPEX is nearly complete; commercial production started July 2025 with dispatches from August.
Chennai Phase 2 CAPEX (approx. Rs. 15-20 crores) planned to start by last quarter of FY’26.
Wada plant CAPEX ongoing as per DRHP; incremental yearly capex based on order book progress.
Total CAPEX for Chennai expected around Rs. 48-50 crores, aiming for peak revenue of Rs. 120 crore by FY’27/FY’28.
Current capacity expected to reach revenue of Rs. 425-450 crore depending on product mix.
Company is scouting for land in Chennai and Maharashtra for further expansion over next 6 months.
Organic growth CAPEX funded by IPO corpus (~Rs. 25 crores), cash accruals, and zero long-term debt.
Exploring inorganic growth opportunities in precision engineering and fasteners with merchant bankers, but no concrete plans yet.

Track Gala Precis. Eng — get its next earnings analysis in your feed

How does Gala Precis. Eng rank vs peers in Industrial Manufacturing?

Pro feature

ThisGala Precis. Eng

Rev 2Mar 3

See where Gala Precis. Eng sits in Industrial ManufacturingSee which companies these are, and every other name in the sector.Open rankings

How does Gala Precis. Eng rank in Industrial Manufacturing?

Compare Gala Precis. Eng against every Industrial Manufacturing company (Q1 FY26) on revenue, margins and earnings-call signals.

View Industrial Manufacturing leaderboard →

What Gala Precis. Eng's management said in earlier quarters

Others in Industrial Manufacturing this season

Aimtron Electronics Ltd (Q3 FY26)
Current Order Book: ₹98 Crores (Page 8) . Key concall takeaways from Aimtron Electronics Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
HLE Glascoat Ltd (Q1 FY25)
Q2 FY24 Revenue from Contract with Customers: ₹22,442.1 Lakhs . Key concall takeaways from HLE Glascoat Ltd's Q1 FY25 earnings call — and how it ranks against…
HLE Glascoat Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹23,102.9 lakhs, down 3.4% YoY (Page 11, 8) . Key concall takeaways from HLE Glascoat Ltd's Q3 FY25 earnings call — and how it…
HLE Glascoat Ltd (Q1 FY24)
Q1 FY24 Revenue from Operations: ₹19,718.7 Lakhs, down 3.5% year-on-year (from ₹20,442.4 Lakhs in Q1 FY23) [Page 7, 8, 10] . Key concall takeaways from HLE…

Compare:vs Mazagon Dock Shipbuilders Ltd vs Indo-MIM Ltd vs Aditya Infotech Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →